Caribou Biosciences
Private company
CARIBOU BIOSCIENCES
Caribou Biosciences is a pioneer in the revolutionary field of CRISPR-Cas genome editing. Our proprietary technology puts us at the forefront of the development of new medical therapies and bio-based products which offer profound benefits to both human health and society as a whole.
Founded
2011
2011
Status
Private company
Private company
Geography
United States of America based
United States of America based
Funding
$74.600 M
$74.600 M
Patents
22
22
Research papers
8
8
Products
No products posted yet
Services
No services posted yet